LNS: Lithotriptor, Extracorporeal Shock-Wave, Urological

Product code LNS, “Lithotriptor, Extracorporeal Shock-Wave, Urological” in FDA's classification database, is a Class II device type under 21 CFR 876.5990 (extracorporeal shock wave lithotripter), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 56 clearances under LNS, 21 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LNS
Regulation
21 CFR 876.5990
Class
II
Panel
Gastroenterology, Urology
Clearances
56
Most recent
Apr 29, 2026
Median review, last 2 years
122 days
Third-party review
Not eligible
Implant
No

What it covers

An extracorporeal shock wave lithotripter is a device that focuses ultrasonic shock waves into the body to noninvasively fragment urinary calculi within the kidney or ureter. The primary components of the device are a shock wave generator, high voltage generator, control console, imaging/localization system, and patient table. Prior to treatment, the urinary stone is targeted using either an integral or stand-alone localization/imaging system. Shock waves are typically generated using electrostatic spark discharge (spark gap), electromagnetically repelled membranes, or piezoelectric crystal arrays, and focused onto the stone with either a specially designed reflector, dish, or acoustic lens. The shock waves are created under water within the shock wave generator, and are transferred to the patient's body using an appropriate acoustic interface. After the stone has been fragmented by the focused shock waves, the fragments pass out of the body with the patient's urine.

The identification in 21 CFR 876.5990, extracorporeal shock wave lithotripter. FDA gives LNS no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K261086Break WaveSonomotion, Inc.Apr 29, 2026Special
K252913Break WaveSonomotion, Inc.Jan 12, 2026Traditional
K242922Extracorporeal Shock Wave Lithotripter (U200)Shenzhen Wikkon Precision Technologies Co., Ltd.Jun 18, 2025Traditional
K221903Delta III ProDornier Medtech America, Inc.Feb 22, 2023Traditional
K213772LM-9300 Plus LithotripterLite-Med, Inc.Jan 19, 2023Traditional
K201001Modulith SLX-F2Karl Storz Endoscopy AmericaMar 30, 2021Traditional
K201074Delta III LithotripterDornier Medtech America, Inc.Sep 3, 2020Traditional
K172084Delta III LithotripterDornier Medtech America, Inc.Aug 8, 2017Special
K170122Delta III LithotripterDornier Medtech AmericaJun 28, 2017Traditional
K151298Gemini XXP-HPDornier Medtech AmericaJul 30, 2015Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 56 with a free account)

Clearances by year

21 LNS 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)275
20251267
20232325
20211348
20201134
2017298
20152133
20142434
2013242
20123111
20113307

Who submits

13 applicants cleared a LNS device since 2011. 76% of the clearances went to applicants in United States, then Taiwan (14%) and China (10%). By type: Traditional 62%, Special 29% and Abbreviated 10%.

ApplicantClearances since 2011
Dornier Medtech America, Inc.4
Dornier Medtech America3
Lite-Med, Inc.3
Sonomotion, Inc.2
Comed Medical Systems Co., Ltd.1
Direx Systems Corp.1
Dornier Medtech Systems1
Edap Tms France1

How FDA classifies it

Class II (special controls) (FDA guidance document: “Guidance for the Content of Premarket Notifications (510(k)'s) for Extracorporeal Shock Wave Lithotripters Indicated for the Fragmentation of Kidney and Ureteral Calculi.”)

From 21 CFR 876.5990. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 876.5990 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LNS clearances declared.

Ask about LNS

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LNS

What is FDA product code LNS?

Product code LNS, “Lithotriptor, Extracorporeal Shock-Wave, Urological” in FDA's classification database, is a Class II device type under 21 CFR 876.5990 (extracorporeal shock wave lithotripter), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 56 clearances under LNS, 21 of them since 2011.

How many 510(k) clearances are there under LNS?

FDA’s 510(k) database listed 56 clearances under LNS as of Oct 29, 2026, 21 of them decided since 2011; the most recent decision was Apr 29, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LNS 510(k)?

For the 3 LNS clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 122 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LNS clearances?

Since 2011: Dornier Medtech America, Inc. (4), Dornier Medtech America (3), Lite-Med, Inc. (3), Sonomotion, Inc. (2) and Comed Medical Systems Co., Ltd. (1). 13 applicants have cleared a LNS device in that time.

Sources

  1. FDA product classification: LNS · Product Classification database
  2. 21 CFR 876.5990: Extracorporeal shock wave lithotripter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LNS · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LNSGet an email when FDA clears, recalls or publishes guidance for LNS devices.

Know what FDA already cleared.